Dr. Farshid Dayyani is a board-certified UCI Health medical oncologist who specializes in the treatment of cancers of the gastrointestinal tract. His clinical interests include colorectal, stomach and esophageal cancers, and anal carcinoma.
Dayyani earned his medical degree at Ludwig Maximilian University of Munich in Germany, where he also received a doctoral degree in immunology. He completed a residency in internal medicine at Beth Israel Deaconess Medical Center in Boston, a teaching hospital of Harvard Medical School. He also completed a fellowship in medical oncology at the University of Texas MD Anderson Cancer Center in Houston.
His goal is to bring leading-edge treatments to patients with gastrointestinal cancers through innovative clinical trials and translational research. He is the author or co-author of more than 40 research papers published in leading medical journals.
Dayyani, who speaks German and Farsi, sees patients at the UCI Health Chao Family Comprehensive Cancer Center and UCI Health Cancer Center — Newport.